Monday
The new trading week kicks off with Jazz Pharmaceuitcals (Nasdaq: JAZZ) reporting its quarterly financials. The maker of narcolepsy drug Xylem and OCD drug Luvox is raking in a ton of dough these days. Analysts see profits more than tripling to $0.60 a share for the quarter.

Tuesday
NABIBiopharmaceuticals (Nasdaq: NABI) and SunOpta (Nasdaq: STKL) report on Tuesday.

Wall Street expects the two companies to go in different directions, with NABI reversing a year-ago profit by ringing up a small quarterly deficit, and SunOpta improving on its profitability.

Wednesday
Molycorp (NYSE: MCP) and FuelCell (Nasdaq: FCEL) step up to the earnings stage on Wednesday.

Molycorp was one of last year's hottest IPOs, fueled by investor excitement for rare-earth specialists. FuelCell is a clean-tech power-plant builder that's been posting narrower deficits lately. Both companies are targeted to post small losses for the quarter, but investors in these two stocks are eyeing the future.    

Thursday
Fuel Tech (Nasdaq: FTEK) is trading essentially where it was a year ago, though it's been a wild ride along the way. Investors are warming up to Fuel Tech as an eco play on fuel consumption. It's not as speculative as you may think. Fuel Tech has posted positive earnings in three of the past four quarters.

Friday
Ann Taylor (NYSE: ANN) closes out the trading week with its quarterly report. This is more than just a specialty retailer. Ann Taylor's emphasis on fashionable apparel for working women makes it a decent proxy for the state of our corporate economy.

Until next week, I remain,

Rick Munarriz

See a stock in this story you'd like to follow? Add it to My Watchlist, which will find all of our Foolish analysis on it.